Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients.
Undre
N A
NA
Fujisawa GmbH, Munich, Germany.
Meiser
B M
BM
Uberfuhr
P
P
Reichart
B
B
Stevenson
P
P
Schäfer
A
A
Möller
A
A
D000328:Adult; D002851:Chromatography, High Pressure Liquid; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008297:Male; D013058:Mass Spectrometry; D008657:Metabolic Clearance Rate; D012044:Regression Analysis; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus